LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Listă Acțiuni・Boston Scientific Corp.

Boston Scientific Corp.

Închisă

SectorSănătate

52.65 -1.74

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

52.51

Maxim

54.33

Indicatori cheie
By Trading Economics
Venit	669M 1.3B
Vânzări	-83M 5.2B
P/E Medie Sector	22.331 51.415
EPS	0.8
Marjă de profit	25.774
Angajați	59,000
EBITDA	116M 1.1B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+66.42% upside

Dividende
By Dow Jones
Următoarele câștiguri	29 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-11B 79B
Deschiderea anterioară	54.39
Închiderea anterioară	52.65

Sentimentul știrilor

By Acuity

24%

76%

42 / 345 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

102.95 / 104.93 Suport & Rezistență

Boston Scientific Corp. Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

22 apr. 2026, 11:22 UTC

Câștiguri

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

4 feb. 2026, 16:14 UTC

Câștiguri

Principalele dinamici ale pieței

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

4 feb. 2026, 12:13 UTC

Câștiguri

Boston Scientific Sees More Growth after Earnings, Sales Rise

6 mai 2026, 20:15 UTC

Câștiguri

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 mai 2026, 20:07 UTC

Câștiguri

Penumbra 1Q Rev $374.8M >PEN

6 mai 2026, 20:07 UTC

Câștiguri

Penumbra 1Q EPS 82c >PEN

22 apr. 2026, 11:07 UTC

Câștiguri

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

22 apr. 2026, 10:32 UTC

Câștiguri

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

22 apr. 2026, 10:31 UTC

Câștiguri

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific 1Q Adj EPS 80c >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific 1Q EPS 90c >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific 1Q Sales $5.2B >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

22 apr. 2026, 10:30 UTC

Câștiguri

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

30 mar. 2026, 15:34 UTC

Market Talk

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

4 feb. 2026, 21:41 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb. 2026, 19:38 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 feb. 2026, 17:32 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

4 feb. 2026, 15:30 UTC

Câștiguri

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

4 feb. 2026, 15:29 UTC

Câștiguri

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

4 feb. 2026, 14:06 UTC

Câștiguri

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

4 feb. 2026, 13:58 UTC

Câștiguri

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 feb. 2026, 13:12 UTC

Câștiguri

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 feb. 2026, 11:32 UTC

Câștiguri

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

4 feb. 2026, 11:31 UTC

Câștiguri

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

4 feb. 2026, 11:30 UTC

Câștiguri

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

4 feb. 2026, 11:30 UTC

Câștiguri

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

4 feb. 2026, 11:30 UTC

Câștiguri

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

4 feb. 2026, 11:30 UTC

Câștiguri

Boston Scientific 4Q Adj EPS 80c >BSX

Comparație

Modificare preț

Boston Scientific Corp. Așteptări

Obiectiv de preț

By TipRanks

66.42% sus

Prognoză pe 12 luni

Medie 89.12 USD 66.42%

Maxim 118 USD

Minim 71 USD

În baza a 27 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBoston Scientific Corp. - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

27 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 27 analiști care au acordat evaluări ale acțiunilor Boston Scientific Corp. - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

102.95 / 104.93Suport & Rezistență

All events are bullish.

Recent bearish events outweigh bullish events.

There are no events.

Sentiment

By Acuity

42 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.